(KRYS) Krystal Biotech - Performance 2.3% in 12m
Compare KRYS with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
69.17%
#8 in Group
Rel. Strength
46.58%
#4082 in Universe
Total Return 12m
2.31%
#40 in Group
Total Return 5y
363.86%
#8 in Group
P/E 61.3
83th Percentile in Group
P/E Forward 24.5
73th Percentile in Group
PEG -
(unknown) Percentile in Group
FCF Yield 2.53%
96th Percentile in Group
12m Total Return: KRYS (2.3%) vs XBI (-11%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
ABBV NYSE AbbVie |
-2.97% | 17.7% | 234% | 84.1 | 16.4 | 0.42 | -49.6% | -19% |
UTHR NASDAQ United Therapeutics |
0.72% | 36.6% | 226% | 13 | 11.3 | 1.43 | 83.8% | 78.5% |
HLN NYSE Haleon |
-3.97% | 23.4% | 39.7% | 25.6 | 20.9 | 1.85 | -38.6% | -24.4% |
AMGN NASDAQ Amgen |
-1.63% | 14.1% | 68.5% | 40.5 | 14.8 | 1.04 | -18.8% | -20% |
LONN SW Lonza |
-7.89% | 0.58% | 37% | 60.5 | 31.8 | 1.16 | 12.6% | -10.3% |
NBIX NASDAQ Neurocrine Biosciences |
-5.39% | -21.4% | 18.7% | 33.6 | 22.8 | 0.27 | 61.5% | 31.6% |
BIM PA Biomerieux |
1.3% | 15.8% | 12.1% | 31.4 | 25.8 | 1.47 | -47.6% | -26.9% |
KMDA NASDAQ Kamada |
1.65% | 24.1% | 14.1% | 27 | 25 | 1 | 58.7% | 15% |
Performance Comparison: KRYS vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for KRYS
Total Return (including Dividends) | KRYS | XBI | S&P 500 |
---|---|---|---|
1 Month | 5.34% | -5.85% | -3.01% |
3 Months | 15.65% | -11.95% | -3.15% |
12 Months | 2.31% | -11.00% | 10.19% |
5 Years | 363.86% | 0.65% | 129.24% |
Trend Score (consistency of price movement) | KRYS | XBI | S&P 500 |
1 Month | 23.8% | -59.8% | -5.5% |
3 Months | 80.3% | -70.5% | -58.4% |
12 Months | -3.40% | -6.9% | 84.1% |
5 Years | 91.5% | -50% | 84.4% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #36 | 11.9% | 8.60% |
3 Month | #20 | 31.4% | 19.4% |
12 Month | #39 | 15.0% | -7.15% |
5 Years | #7 | 361% | 102% |
FAQs
Does KRYS Krystal Biotech outperforms the market?
Yes,
over the last 12 months KRYS made 2.31%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.00%.
Over the last 3 months KRYS made 15.65%, while XBI made -11.95%.
Over the last 3 months KRYS made 15.65%, while XBI made -11.95%.
Performance Comparison KRYS vs Indeces and Sectors
KRYS vs. Indices KRYS is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -2.54% | 8.35% | 2.17% | -7.88% |
US NASDAQ 100 | QQQ | -1.56% | 9.40% | 2.94% | -6.29% |
US Dow Jones Industrial 30 | DIA | -2.74% | 7.48% | 1.25% | -7.20% |
German DAX 40 | DAX | -1.24% | 8.72% | -14.6% | -19.4% |
Shanghai Shenzhen CSI 300 | CSI 300 | -2.25% | 5.11% | 17.4% | -6.81% |
Hongkong Hang Seng | HSI | -4.51% | 2.57% | 11.4% | -15.0% |
India NIFTY 50 | INDA | -3.57% | -2.53% | 12.5% | 1.61% |
Brasil Bovespa | EWZ | -2.65% | -2.95% | 10.2% | 14.1% |
KRYS vs. Sectors KRYS is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -1.0% | 9.15% | -5.94% | -16.9% |
Consumer Discretionary | XLY | -3.30% | 9.17% | -1.19% | -11.8% |
Consumer Staples | XLP | -5.33% | 7.18% | 1.33% | -8.72% |
Energy | XLE | -3.63% | -2.68% | -3.41% | 1.50% |
Financial | XLF | -3.02% | 8.04% | -9.99% | -19.9% |
Health Care | XLV | -2.96% | 8.50% | 6.87% | 0.62% |
Industrial | XLI | -2.85% | 6.03% | 2.88% | -6.22% |
Materials | XLB | -3.64% | 4.83% | 10.3% | 6.25% |
Real Estate | XLRE | -4.58% | 8.03% | 5.29% | -11.1% |
Technology | XLK | -1.41% | 9.35% | 7.29% | 0.30% |
Utilities | XLU | -5.83% | 4.52% | 3.05% | -22.9% |
Aerospace & Defense | XAR | -1.94% | 4.06% | -1.75% | -18.6% |
Biotech | XBI | 2.02% | 11.2% | 19.9% | 13.3% |
Homebuilder | XHB | -3.04% | 5.19% | 21.6% | 10.0% |
Retail | XRT | -4.84% | 5.84% | 6.25% | 7.10% |